Translational research for childhood blood cancers
Part of Cancer clinical trials.
This study looks at childhood leukemia and related blood disorders. It may help researchers learn more about the diseases and how to improve treatments for children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these diagnoses: ALL, AML, MPAL, JMML, or MDS
- You may also qualify if you are a normal bone marrow donor
- You (or your parent/guardian) can understand English or Chinese well enough for the study
- You and/or your parent/guardian are willing to take part (no refusal)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how personalized (tailored) genetic testing can help guide care for children with cancer. It may help match treatment choices to each child’s genetic risk, and it includes optional return of germline (inherited) test results.
This study looks at gene patterns in people with blood cancers to better understand the disease and find possible treatments. If you are being tested for a blood cancer or have a blood cancer that came back or got worse, you may be able to join.
This study looks at whether a simple blood test can help track how well treatment is working in children with leukemia. It may help doctors understand the disease better and guide future care.
This trial looks at blood and bone marrow samples from children and teens whose leukemia has come back or is hard to treat. The goal is to better understand the disease and guide future options for these patients.
This study collects and stores blood and bone marrow samples from young people with certain blood cancers so doctors can do genetic (“genomic”) testing now and in the future. It may help improve understanding of the disease and support better matching of care for patients.
This trial uses a rapid type of genetic testing (whole genome sequencing) to look at the DNA of children and young adults with cancer. The goal is to better understand each person's cancer and potentially guide treatment decisions.
Hear when a new Childhood Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.